For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
American Renal Associates
(NYSE: ARA) Add to Portfolio
$8.39
-0.11 (-1.29%)
as of Sep 19, 2019

Last 8.39
Change -0.11 (-1.29%)
Open 8.29
Prev. Close 8.50
Today's Range
8.18 8.82
52wk Range
5.48 23.49
Volume 263,453
Avg Volume 326,975
Sector SIC-8090 Services-Misc Health & Allied Services, NEC

Recent Headlines
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations (full story)
ARA: 8.39 (-0.11), AAC: 0.80 (-0.04), TDOC: 68.73 (+1.28), INGN: 49.09 (+0.63)
--Provides 2019 Outlook and Preliminary 2020 Outlook (full story)
ARA: 8.39 (-0.11)
Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of American Renal Associates Holdings, Inc. (NYSE: ARA) filed a class action complaint against the company for alleged violations of the Securitie (full story)
ARA: 8.39 (-0.11), TXT: 51.43 (-0.86)
Bragar Eagel & Squire is investigating certain officers and directors of Lannett Company, Inc. (NYSE: LCI), Molson Coors Brewing Company (NYSE: TAP), AxoGen, Inc. (NASDAQ: AXGN), and American Renal Associates Holdings, Inc. (NYSE: (full story)
AXGN: 14.22 (+0.23), ARA: 8.39 (-0.11), TAP: 55.04 (unch), LCI: 13.41 (-0.59)
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in American Renal Associates Holdings, Inc. (NYSE: ARA) shares. (full story)
ARA: 8.39 (-0.11)
 
Performance Comparison
Name Today 3-Month 1-Year
ARA -1.29% +24.30% -58.99%
Growth Rates
YTD -27.17%
1-Year -57.73%
3-Year -55.52%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.